INTERSTITIAL LUNG DISEASE (ILD)
Clinical trials for INTERSTITIAL LUNG DISEASE (ILD) explained in plain language.
Never miss a new study
Get alerted when new INTERSTITIAL LUNG DISEASE (ILD) trials appear
Sign up with your email to follow new studies for INTERSTITIAL LUNG DISEASE (ILD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare lung disease: JAK inhibitors vs standard care
Disease control Recruiting nowThis study tests whether JAK inhibitors work better than calcineurin inhibitors as the first treatment for lung scarring in people with antisynthetase syndrome. About 80 adults with active lung disease will be followed for 12 months to see which drug improves breathing and surviv…
Matched conditions: INTERSTITIAL LUNG DISEASE (ILD)
Phase: NA • Sponsor: China-Japan Friendship Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New combo therapy for lung scarring and high blood pressure under study
Disease control Recruiting nowThis study tests a new inhaled drug, mosliciguat, added to an existing treatment (treprostinil) for people with high blood pressure in the lungs caused by lung scarring. The goal is to see if the combination is safe and tolerable. About 20 adults with this condition will particip…
Matched conditions: INTERSTITIAL LUNG DISEASE (ILD)
Phase: PHASE2 • Sponsor: Pulmovant, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New inhaled drug aims to treat lung scarring with fewer side effects
Disease control Recruiting nowThis early-stage trial tests a single dose of an inhaled drug called RJ026 in 42 healthy volunteers and 42 people with interstitial lung disease (ILD). The goal is to see how much drug reaches the lungs and blood, and whether it is safe. Researchers hope that inhaling the drug wi…
Matched conditions: INTERSTITIAL LUNG DISEASE (ILD)
Phase: PHASE1 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Could a traditional chinese medicine help stop lung scarring?
Disease control Recruiting nowThis study tests whether tetrandrine tablets can improve lung function in people with interstitial lung disease caused by connective tissue disease (like lupus or scleroderma). One hundred adults will receive either tetrandrine or a placebo for 24 weeks, alongside their usual tre…
Matched conditions: INTERSTITIAL LUNG DISEASE (ILD)
Phase: PHASE4 • Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Lung transplant study tests whether ECMO should be used routinely or only when needed
Disease control Recruiting nowThis study compares two ways of using a heart-lung support machine (ECMO) during lung transplants: using it routinely for all patients versus using it only when problems arise. About 218 adults with end-stage lung disease will take part. The goal is to see which approach leads to…
Matched conditions: INTERSTITIAL LUNG DISEASE (ILD)
Phase: NA • Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New breath and blood tests could speed up lung disease diagnosis
Diagnosis Recruiting nowThis study aims to find better, non-invasive tests to diagnose and predict the course of interstitial lung disease (ILD). Researchers will test blood and breath samples from 750 people, including pigeon fanciers at high risk for ILD and patients already diagnosed. The goal is to …
Matched conditions: INTERSTITIAL LUNG DISEASE (ILD)
Sponsor: University of Dundee • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
AI reads your heartbeat to catch silent killer in lung patients
Diagnosis Recruiting nowThis study tests whether an artificial intelligence (AI) tool that analyzes a simple ECG can help doctors find undiagnosed pulmonary hypertension (high blood pressure in the lungs) in people with interstitial lung disease. About 900 adults with severe lung scarring will be random…
Matched conditions: INTERSTITIAL LUNG DISEASE (ILD)
Phase: NA • Sponsor: Tempus AI • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC
-
Robot vs. doctor: which lung biopsy method is more accurate?
Diagnosis Recruiting nowThis study tests whether using a robotic arm during a lung biopsy helps doctors get better tissue samples to diagnose interstitial lung disease. About 30 adults with unclear CT scans will be randomly assigned to either standard or robotic-assisted bronchoscopy. The goal is to see…
Matched conditions: INTERSTITIAL LUNG DISEASE (ILD)
Phase: NA • Sponsor: University of Zurich • Aim: Diagnosis
Last updated Jun 27, 2026 12:02 UTC
-
Hypnosis may ease breathlessness without drugs
Symptom relief Recruiting nowThis study tests whether three 15-minute hypnosis sessions can help people with persistent breathlessness from cancer, COPD, interstitial lung disease, or chronic heart failure feel more in control of their breathing. Researchers will measure changes using a standard questionnair…
Matched conditions: INTERSTITIAL LUNG DISEASE (ILD)
Phase: NA • Sponsor: University Hospital, Geneva • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Minty fresh hope: l-menthol tested for lung disease breathlessness
Symptom relief Recruiting nowThis study tests whether L-menthol, a minty compound, can reduce breathlessness and help people with interstitial lung disease (ILD) exercise longer. About 20 adults with ILD will try L-menthol and a placebo in random order, comparing their breathing and exercise ability. The goa…
Matched conditions: INTERSTITIAL LUNG DISEASE (ILD)
Phase: PHASE2 • Sponsor: Region Skane • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Streamlined lung care cuts patient travel time
Symptom relief Recruiting nowThis study aims to see if bundling all routine tests and doctor visits into one coordinated hospital trip can save time for people with interstitial lung disease. About 152 adults with the condition will either receive standard care or the new streamlined approach. The goal is to…
Matched conditions: INTERSTITIAL LUNG DISEASE (ILD)
Phase: NA • Sponsor: Hospital de Granollers • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Scientists probe the mystery of breathlessness to unlock better treatments
Knowledge-focused Recruiting nowThis study aims to understand why breathlessness varies among people with different lung diseases like COPD, asthma, and ILD. Researchers will measure lung function, exercise ability, and breathing patterns in 75 participants (50 with lung disease and 25 healthy controls). The go…
Matched conditions: INTERSTITIAL LUNG DISEASE (ILD)
Sponsor: University Hospitals, Leicester • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Could home monitoring replace half of clinic visits for lung fibrosis?
Knowledge-focused Recruiting nowThis study is testing whether people with pulmonary fibrosis can safely replace half of their regular clinic visits with home monitoring. Participants will use a home spirometer, pulse oximeter, and a smartphone app to track their health and communicate with their care team. The …
Matched conditions: INTERSTITIAL LUNG DISEASE (ILD)
Phase: NA • Sponsor: Erasmus Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
New study aims to cut diagnostic delays for lung scarring patients
Knowledge-focused Recruiting nowThis study tests whether bundling key tests like scans and lung function tests into a single, fast-tracked appointment can help people with suspected interstitial lung disease get a diagnosis sooner. About 92 adults will be randomly assigned to either the usual step-by-step testi…
Matched conditions: INTERSTITIAL LUNG DISEASE (ILD)
Phase: NA • Sponsor: Hospital de Granollers • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC